Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (181-190 of 1,422) with videos related to

Pageof 143
Sort By:
European Heart Journal|October 1, 2025
Transthyretin amyloid cardiomyopathy: from cause to novel treatmentsMarianna Fontana, Alberto Aimo, Michele Emdin, et al.
European Heart Journal|September 21, 2006
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT TrialUchechukwu K Sampson, Marc A Pfeffer, John J V McMurray, et al.
Circulation|August 29, 2015
Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health StudyGabriela Querejeta Roca, Susan Redline, Brian Claggett, et al.
Journal of the American Heart Association|July 28, 2020
The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19Senthil Selvaraj, Stephen J Greene, Sameed Ahmed M Khatana, et al.
Circulation|May 23, 2022
Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection FractionMuthiah Vaduganathan, Brian L Claggett, Riccardo M Inciardi, et al.
Clinical Trials (London, England)|August 24, 2012
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical studyLihui Zhao, Lu Tian, Hajime Uno, et al.
Clinical Transplantation|September 24, 2021
Excess mortality in solid organ transplant recipients hospitalized with COVID-19: A large-scale comparison of SOT recipients hospitalized with or without COVID-19Karola S Jering, Martina M McGrath, Finnian R Mc Causland, et al.
Heart (British Cardiac Society)|June 5, 2021
Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical careRishi J Desai, Elisabetta Patorno, Muthiah Vaduganathan, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2013
Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS studyGabriela Querejeta Roca, Susan Redline, Naresh Punjabi, et al.
European Heart Journal|June 16, 2018
Heart failure with preserved ejection fraction: from mechanisms to therapiesCarolyn S P Lam, Adriaan A Voors, Rudolf A de Boer, et al.
Pageof 143

Showing results (181-190 of 1,422) with videos related to

Sort By:
Pageof 143
European Heart Journal|October 1, 2025
Transthyretin amyloid cardiomyopathy: from cause to novel treatmentsMarianna Fontana, Alberto Aimo, Michele Emdin, et al.
European Heart Journal|September 21, 2006
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT TrialUchechukwu K Sampson, Marc A Pfeffer, John J V McMurray, et al.
Circulation|August 29, 2015
Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health StudyGabriela Querejeta Roca, Susan Redline, Brian Claggett, et al.
Journal of the American Heart Association|July 28, 2020
The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19Senthil Selvaraj, Stephen J Greene, Sameed Ahmed M Khatana, et al.
Circulation|May 23, 2022
Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection FractionMuthiah Vaduganathan, Brian L Claggett, Riccardo M Inciardi, et al.
Clinical Trials (London, England)|August 24, 2012
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical studyLihui Zhao, Lu Tian, Hajime Uno, et al.
Clinical Transplantation|September 24, 2021
Excess mortality in solid organ transplant recipients hospitalized with COVID-19: A large-scale comparison of SOT recipients hospitalized with or without COVID-19Karola S Jering, Martina M McGrath, Finnian R Mc Causland, et al.
Heart (British Cardiac Society)|June 5, 2021
Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical careRishi J Desai, Elisabetta Patorno, Muthiah Vaduganathan, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2013
Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS studyGabriela Querejeta Roca, Susan Redline, Naresh Punjabi, et al.
European Heart Journal|June 16, 2018
Heart failure with preserved ejection fraction: from mechanisms to therapiesCarolyn S P Lam, Adriaan A Voors, Rudolf A de Boer, et al.
Pageof 143